Personalized medicines as percent of new molecular entities 2014-2018

This statistic displays the percentage of personalized medicines among FDA approved new molecular entities from 2014 to 2018. In 2015, personalized medicines accounted for 28 percent of the total FDA approved new molecular entities, while in 2018 they accounted for 42 percent of approved new molecular entities.

Personalized medicines as a percentage of FDA approved new molecular entities from 2014 to 2018

Share of new molecular entities
201842%
201734%
201627%
201528%
201421%
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

2019

Region

United States

Survey time period

2014 to 2018

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Personalized medicine"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.